The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Stoke Therapeutics Inc shares valued at $152,185 were sold by Ticho Barry on Jun 03 ’24. At $15.22 per share, Ticho Barry sold 10,000 shares. The insider’s holdings dropped to 2,485 shares worth approximately $33075.35 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Nash Huw M. sold 50,000 shares, netting a total of over 769,500 in proceeds. Following the sale of shares at $15.39 each, the insider now holds 0 shares.
Before that, Kaye Edward M. MD had sold 42,350 shares from its account. In a trade valued at $653,529, the CEO traded Stoke Therapeutics Inc shares for $15.43 each. Upon closing the transaction, the insider’s holdings decreased to 42,350 shares, worth approximately $0.36 million.
As published in a research note from TD Cowen on March 26, 2024, Stoke Therapeutics Inc [STOK] has been rated up from a Market perform to an Outperform. As of July 25, 2023, TD Cowen has decreased its “an Outperform” rating to a “Market perform” for STOK. Earlier on May 01, 2023, BofA Securities upgraded its rating. Their new recommendation was “a Neutral” for STOK stock which previously was a “an Underperform”.
Analyzing STOK Stock Performance
During the last five days, there has been a drop of approximately -9.82%. Over the course of the year, Stoke Therapeutics Inc shares have jumped approximately 153.04%. Shares of the company reached a 52-week high of $17.58 on 06/13/24 and a 52-week low of $4.09 on 02/13/24. A 50-day SMA is recorded $13.67, while a 200-day SMA reached $7.69. Nevertheless, trading volume fell to 1.02 million shares from 1.47 million shares the previous day.
Support And Resistance Levels for Stoke Therapeutics Inc (STOK)
According to the 24-hour chart, there is a support level at 12.92, which, if violated, would cause prices to drop to 12.53. In the upper region, resistance lies at 13.54. The next price resistance is at 13.77. RSI (Relative Strength Index) is 42.36 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.66, which suggests the price will decrease in the coming days. Percent R is at 88.59%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
